Results 191 to 200 of about 1,887,446 (306)

SPHINX31 acts as a SRPK1 inhibitor targeting the ATR/DNA‐PKcs/CHK1 replicative checkpoint to inhibit cell growth in non‐small cell lung cancer

open access: yesMolecular Oncology, EarlyView.
The kinase SRPK1 directly interacts with the protein TOPBP1 and regulates the pre‐mRNA splicing of WIZ thereby contributing to the activation of the ATR/CHK1 replicative checkpoint in response to replicative stress. This allows cancer cells' genomic stability and survival.
Amani Shreim   +17 more
wiley   +1 more source

Epigenetic aging during the COVID-19 pandemic: A prospective longitudinal study with prepandemic baseline data in children, adolescents, and adults. [PDF]

open access: yesProc Natl Acad Sci U S A
Schowe AM   +11 more
europepmc   +1 more source

[Robert Emery's Business Card with a Mission Statement]

open access: yes
The business card and mission statement of Robert Emery, a Founding Board Member of Coalition for Aging LGBT, from the Coalition for Aging LGBT Records (The Dallas Way)
Coalition for Aging LGBT
core  

Mutant p53R273H disrupts PDPK1 homodimerization and contributes to PDPK1 activation

open access: yesMolecular Oncology, EarlyView.
How mutant p53R273H drives AKT signaling is unclear. We show that p53R273H, but not wild‐type, directly binds PDPK1 via a mutation‐dependent conformational change. This interaction disrupts inhibitory PDPK1 homodimerization and enhances AKT phosphorylation.
Mei Chee Lim   +11 more
wiley   +1 more source

Ages of Ages

open access: yes
Ages of Ages is for SATB a capella choir. It is inspired by text taken from the medieval Old Hispanic chant, León 8, fol. 273: Et non deficiet ex te vir qui compleat voluntatem meam; and León 8, fol. 88v: Gloria et honor patri et filio et spiritui sancto et nunc and semper et in saecula saeculorum. An English translation is used for this piece.
openaire   +1 more source

Characterization of therapeutic antibodies targeting lymphatic and vascular resistance factor for the treatment of hypervascularized and highly metastatic cancers

open access: yesMolecular Oncology, EarlyView.
LVRF (lymphatic and vascular resistance factor) is a VEGFA splice variant upregulated in response to anti‐angiogenic therapy that fosters tumor adaptation through enhanced vascularization, lymphangiogenesis, and metastatic dissemination. Targeting LVRF with fully human neutralizing antibodies disrupts these processes and limits resistant tumor growth ...
Marion David   +12 more
wiley   +1 more source

[LGBT Friendly Senior Housing Metric]

open access: yes
LGBT Friendly Senior Housing Metric document from the Coalition for Aging LGBT Records (The Dallas Way)
Coalition for Aging LGBT
core  

Reprogramming tumor cells with LCOR mRNA nanotherapy to enhance immunotherapy

open access: yesMolecular Oncology, EarlyView.
LCOR (Ligand‐dependent corepressor) mRNA encapsulated in polymeric nanoparticles restores LCOR activity in tumor cells, constraining aggressive tumor cell states and increasing tumor immunogenicity. This reprogramming makes tumor cells more vulnerable to T‐cell attack and enhances their response to immune‐checkpoint immunotherapy.
Gabriel Serra‐Mir   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy